ifosfamide and mitomycin

ifosfamide has been researched along with mitomycin in 143 studies

Research

Studies (143)

TimeframeStudies, this research(%)All Research%
pre-19908 (5.59)18.7374
1990's54 (37.76)18.2507
2000's54 (37.76)29.6817
2010's23 (16.08)24.3611
2020's4 (2.80)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Sculier, JP1
Artal, A; Chacon, JI; Feliu, J; Garcia de Paredes, ML; Garcia Giron, C; Garrido, P; Gonzalez Baron, M; Ordoñez, A; Zamora, P1
Thongprasert, S1
Antonakopoulos, GN; Darnton, SJ; Matthews, HR; Newman, J1
Chauffert, B; Dimanche-Boitrel, MT; Genne, P; Jeannin, JF; Onier, N; Petit, JM1
Gatzemeier, U; Heckmayr, M; Hossfeld, DK; Kaukel, E; Koschel, G; Neuhauss, R2
Alonso Muñoz, C; Blanco Guerrero, R; Climent Durán, MA; Germà Lluch, JR; López López, JJ; López Pousa, A; Mercedes Ramírez, A1
Vogelzang, NJ1
Burmester, H; Carroll, KB; Chang, J; Cuthbert, A; Gomm, SA; Hall, P; Thatcher, N1
Abad, A; Barnadas, A; Carles, J; Ribelles, N; Rosell, R; Solano, V1
Currie, DC; Drake, JS; Earl, HM; Harper, PG; Miles, DW; Rudd, R; Souhami, RL; Spiro, SG; Tobias, JS1
Abad-Esteve, A; Barnadas, A; Carles, J; Culubret, M; Fernandez, C; Moreno, I; Ribelles, N; Rosell, R1
Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y1
Häussinger, K; Jungbluth, H; Krieger, H; Laumen, R; Otto, M; von Pawel, J1
Akagi, T; Hara, M; Nanba, K; Obama, T; Ochi, J; Ozaki, Y; Saegusa, M; Tanahashi, T; Tsushima, T; Yoshimoto, J1
Chetiyawardana, AD; Cullen, MH; Joshi, R; Woodroffe, CM1
Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R1
Akiyama, S; Ichihashi, H; Takagi, H1
Hino, K; Ibaraki, T; Katou, Y; Kiyozuka, Y; Maruyama, M; Nabuchi, K; Ninomiya, Y; Noda, T; Okamura, Y; Oku, M1
Akahoshi, Y; Kasai, C; Nishimoto, Y; Takeuchi, S1
Bakowski, MT; Crouch, JC1
Herrmann, R; Kreusser, W; Ritz, E; Tschöpe, W1
Abad, A; Ariza, A; Barnadas, A; Carles, J; Fernandez-Vasalo, G; Pellicer, I; Rosell, R; Sanchez, JJ1
Addamo, GF; Ardizzoni, A; Baldini, E; Borghini, U; Bruzzi, P; Conte, PF; De Marinis, F; Lionetto, R; Pennucci, MC; Portalone, L1
Barduagni, M; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A1
Camps, C; Font, A; Gómez-Codina, J; Li, S; Martínez, E; Molina, F; Moreno, I; Pifarré, A; Rosell, R; Skacel, Z1
Cullen, MH2
Macbeth, F; Milroy, R1
Boni, C; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A1
Antonakopoulos, GN; Darnton, SJ; Duffy, JP; Matthews, HR; Newman, J1
Allen, SM; Cullen, MH; Darnton, SJ; Duffy, JP; Matthews, HR; Walker, SJ1
Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ1
Blanco, E; Colmenarejo, A; de la Gándara, I; Espinosa, E; Feliu, J; García Girón, C; Garrido, P; González Barón, M; Moyano, A; Ordóñez, A1
Chastang, C; Depierre, A; Jacoulet, P; Janicot, H; Lebeau, B; Lombard, JN; Milleron, B; Moro, D; Paillot, N; Quoix, E1
Camps, C; Font, A; Gómez-Codina, J; Maestre, J; Milla, A; Molina, F; Moreno, I; Rosell, R1
Arcangeli, G; Marini, G; Marpicati, P; Meriggi, F; Milano, S; Simoncini, E; Zaniboni, A1
Artal, A; Barón, JM; Berrocal, A; Feliu, J; García Girón, C; Garrido, P; González Barón, M; Ordóñez, A1
Allen, SM; Darnton, SJ; Edwards, CW; Matthews, HR1
Köpf-Maier, P; Sass, G1
Darnton, SJ; Ferry, DR; Jenner, K; Matthews, HR; Steyn, RS1
Allen, SM; Cullen, MH; Darnton, SJ; Duffy, JP; Matthews, HR1
Di Fabio, D; Marini, G; Milano, S; Mombelloni, G; Ottoni, DB; Zaniboni, A; Zorzi, F1
Brandt, A; Palmer, AJ1
Cachat, F; Guignard, JP1
Shimizu, Y1
Crinó, L; Mosconi, AM; Tonato, M1
Corgna, E; Crinò, L; Darwish, S; Minotti, V; Mosconi, AM; Palladino, MA; Porrozzi, S; Tonato, M1
Cooper, K; Sur, M; Sur, RK; Taylor, L1
Akusawa, H; Horie, T; Kadota, A; Koya, Y; Masutani, M; Ohchi, Y; Takahashi, N; Tanigawa, S1
Buckner, JC; Lewis, JE; McElroy, EA1
Antilli, A; Ardizzoni, A; Baldini, E; Bandera, M; Barbera, S; Borghini, U; Cacciani, GC; Crippa, M; De Marinis, F; Ferrara, G; Fioretti, M; Galeasso, G; Lanfranco, C; Lepidini, G; Migliorino, MR; Noseda, MA; Pennucci, MC; Portalone, L; Raimondi, M; Rinaldi, M; Romano, F; Rosso, R; Salvati, F; Sunseri, G; Tibaldi, C1
Ip, M; Lam, WK; Tsang, KW1
Choi, BG; Han, JY; Hong, YS; Kim, HK; Lee, KS; Moon, H1
Hongo, A; Ikuhashi, H; Kobashi, Y; Kodama, J; Kudo, T; Miyagi, Y; Mizutani, Y; Okuda, H; Yoshinouchi, M1
Baumöhl, J; Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Recloux, P; Sculier, JP; Thiriaux, J; van Cutsem, O; van Houtte, P; Zacharias, C1
Günzburg, WH; Karle, P; Renner, M; Renz, R; Salmons, B1
Bessell, E; Billingham, LJ; Chetiyawardana, AD; Connolly, CK; Cook, JE; Cullen, MH; Ferry, DR; Gower, NH; Joshi, R; Rudd, RM; Souhami, RL; Spiro, SG; Tobias, J; Trask, C; Woodroffe, CM1
Adamo, V; Barni, S; Bianco, R; Ceribelli, A; Crinò, L; Cruciani, G; De Marinis, F; Di Costanzo, F; Ferrara, G; Gozzelino, F; Gridelli, C; Marangolo, M; Masotti, A; Portalone, L; Ravaioli, A; Ricci, S; Rinaldi, M; Sassi, M; Scagliotti, GV; Tonato, M1
Abad, A; Camps, C; Cantó, A; Gómez-Codina, J; Javier Sánchez, J; Maestre, J; Padilla, J; Roig, J; Rosell, R1
Cheverton, PD; Davidson, NG; Davis, AS; Snooks, S; Woods, J1
Ochiai, K1
Sandler, A1
Alexopoulos, CG; Baumöhl, J; Berghmans, T; Florin, MC; Klastersky, J; Koumakis, G; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Schmerber, J; Sculier, JP; Thiriaux, J; Zacharias, C1
Aktoğu, S; Büyükşirin, M; Capa, G; Durak, H; Erkmen, G; Ertay, T; Ozbilek, E; Sayit, E1
Gérinière, L; Souquet, PJ1
Arnau Obrer, A; Cantó Armengod, A; Cervera Juan, A; Granell Gil, M; Martín Díaz, E; Pérez Alonso, D; Regueiro Mira, F; Roch Pendería, S1
Arnau Obrer, A; Cañizares Carretero, M; Cantó Armengod, A; Cervera Juan, A; Granell Gil, M; Martín Díaz, E; Pérez Alonso, D; Regueiro Mira, F; Roch Tejerina, S1
Archer, VR; Darnton, SJ; Ferry, DR; Mulholland, PJ; Stocken, DD1
Rixe, O1
Baud, M; Collon, T; Febvre, M; Le Guen, Y; Lebeau, B; Touboul, E; Urban, T1
Burgut, R; Erkisi, M; Erkurt, E; Kocabas, A; Tunali, C; Zeren, H1
Blanchon, F; Braun, D; Bréchot, JM; Breton, JL; Chastang, C; Chevret, S; Clavier, J; Coëtmeur, D; Depierre, A; Foucher, P; Gouva, S; Janicot, H; Lebas, FX; Lebeau, B; Leclerc, P; Lemarié, E; Level, MC; Milleron, B; Monchâtre, M; Moro-Sibilot, D; Paillot, N; Quoix, E; Rodier, JM; Terrioux, P; Thiberville, L; Villeneuve, A; Westeel, V1
Rosell, R1
Billingham, LJ; Cullen, MH1
Buckner, JC; Edmonson, JH; Foo, ML; Gunderson, LL; Haddock, MG; Mahoney, MR; Maples, WJ; O'Connor, MI; Petersen, IA; Pritchard, DJ; Rock, MG; Shives, TC; Sim, FH; Stafford, SL1
Chu, DT; Li, JL; Qu, FL; Sun, Y; Zhang, XR1
Hosomi, Y; Shibuya, M1
Bathers, S; Billingham, LJ; Bryan, S; Burton, A; Cullen, MH1
Crinò, L1
Du, CW; Li, DR; Lin, W; Lin, Y; Lin, YC; Wu, MY1
Bilkei-Gorzo, A; Michel, K; Palkovits, M; Racz, I; Toth, ZE; Zimmer, A1
Anderson, H; Ashcroft, L; Beresford, C; Burt, PA; Clemons, M; Danson, S; Dowd, I; Fairve-Finn, C; Hassan, J; Middleton, MR; O'Byrne, KJ; Ranson, M; Stout, R; Thatcher, N1
Ernst, H; Fahrig, R; Fiedler, B; Heinrich, JC; Krupitza, G; Leisser, C; Nickel, B; Praha, C; Scherthan, H; Sonntag, D; Wilfert, F1
Brasiūnas, V; Brasiūniene, B; Inciūra, A; Juozaityte, E1
Archer, VR; Casson, AG; Darnton, SJ; Ferry, DR; Mulholland, PJ; Stocken, DD1
Barrow, E; Barrow, WW; Flavin, MT; Lin, YM; Suling, WJ; Westbrook, L; Xu, ZQ1
Berghmans, T; Corhay, JL; Efremidis, A; Giner, V; Koumakis, G; Lafitte, JJ; Lecomte, J; Lothaire, P; Mommen, P; Ninane, V; Paesmans, M; Richez, M; Sculier, JP; Thiriaux, J; Van Houtte, P; Wackenier, P1
Müller, H; Nakchbandi, V1
Berghmans, T; Corhay, JL; Efremidis, A; Giner, V; Koumakis, G; Lafitte, JJ; Lecomte, J; Lothaire, P; Mommen, P; Ninane, V; Richez, M; Sculier, JP; Thiriaux, J; VanHoutte, P; Wackenier, P1
Amadori, S; Anak, O; Beeldens, F; De Witte, T; Denzlinger, C; Fabris, P; Hagemeijer, A; Ho, A; Leone, G; Mandelli, F; Muus, P; Selleslag, D; Stauder, R; Suciu, S; Vignetti, M; Willemze, R1
Eisen, TG; Gower, NH; Gregory, WM; Harper, PG; Hatton, M; James, LE; Johnson, PW; Lee, SM; Littler, JA; Martin, WM; Qian, W; Rankin, EM; Rudd, RM; Spiro, SG1
de Bree, E; Relakis, K; Romanos, J; Tsiftsis, DD1
Breton, JL; Debieuvre, D; Depierre, A; Haller, MA; Herman, D; Lebas, FX; Level, MC; Mercier, M; Milleron, B; Moro-Sibilot, D; Puyraveau, M; Quoix, E; Richard, P; Westeel, V1
Girling, DJ; Hopwood, P; Stephens, RJ; Thatcher, N1
Furuhashi, M; Ishikawa, K; Ishizuka, T; Kidokoro, K; Kuno, N; Miyazaki, K; Mizuno, K; Mizuno, M; Nakagawa, A; Suzuki, S; Yoshida, K1
Ishida, T; Kiwada, H; Nguyen, LT1
Berghmans, T; Sculier, JP1
Braun, D; Depierre, A; Lebeau, B; Milleron, B; Moro-Sibilot, D; Quoix, E; Westeel, V1
Govindan, R1
Ferry, DR; Tho, LM1
Berghmans, T; Meert, AP; Ninane, V; Sculier, JP1
Anderson, H; Ashcroft, L; Baka, S; Booton, R; Dark, G; Dunlop, D; Laurence, V; Lorigan, P; Nicolson, M; O'Brien, M; O'Byrne, K; Snee, M; Thatcher, N1
Depierre, A1
Alexander, JP; Cravatt, BF1
Atil, H; Aysan, T; Cok, G; Göksel, T; Güzelant, A; Soyer, S1
Bowman, E; Coskun, O; Gendelman, HE; Laurie, C; Mosley, RL; Reynolds, A1
Ashcroft, L; Booten, R; Booton, R; Heighway, J; Morris, J; Thatcher, N; Ward, T1
Jang, JH; Yotsu-Yamashita, M1
Ashcroft, L; Booton, R; Heighway, J; Morris, J; Thatcher, N; Ward, T1
Ahn, JS; Ahn, MJ; Hwang, IG; Im, YH; Kang, WK; Lee, SC; Lim, HY; Park, BB; Park, K1
Eyster, CA; Olson, AL1
Chen, SW; Chiang, LW; Huang, HL; Lin, KJ; Pei, K; Yen, TC; Yu, CS1
Deutsch, E; Loriot, Y; Mordant, P; Olaussen, KA; Soria, JC1
Bhatt, L; Fernando, I1
Andersson, JO; Backhans, A; Christensson, B; Lebbad, M; Ljungström, B; Mattsson, JG; Svärd, SG1
Kochanek, S; Larochelle, N; Lochmüller, H; Rieger, N; Schermelleh, L; Schiedner, G; Stucka, R; Wolf, E1
Gordon, TP; Haberberger, RV; Jackson, MW; Park, K1
Brioschi, M; Ceraulo, D; Cereda, S; Fugazza, C; Ghidini, M; Nicoletti, R; Reni, M; Rognone, A; Villa, E1
Helming, L1
Berchier, MC; Berghmans, T; Bosschaerts, T; Giner, V; Lafitte, JJ; Leclercq, N; Lewin, D; Meert, AP; Paesmans, M; Scherpereel, A; Sculier, JP1
David, P; Depierre, A; Ducoloné, A; Milleron, B; Molinier, O; Monnet, E; Mouillet, G; Puyraveau, M; Quoix, E; Westeel, V; Zalcman, G1
Badie, H; Bu, G; Cai, L; Chen, Y; Gage, FH; Hong, W; Johnson, PF; Lipton, SA; Loo, LS; Mobley, WC; Mu, Y; Ranscht, B; Thompson, RC; Wang, X; Wu, C; Xu, H; Yang, B; Zhang, D; Zhang, X; Zhang, YW; Zhao, Y; Zhou, Y1
Ozdemir, O; Ozdemir, P; Ozhan, MH; Uluer, H; Veral, A1
Bar-Sela, G; Miller, RC; Novotny, PJ; Sio, TT; Sohawon, S; Thariat, J; Van Houtte, P; Vu, CC1
Haddock, M; Mahoney, M; Maples, W; Markovic, SN; O'Connor, MI; Okuno, S; Petersen, I; Shives, T; Sim, F1
Baxley, A; Khawandanah, M; Pant, S1
Bao, H; Chen, H; Cui, P; Deng, G; Kong, H; Lu, K; Mu, G; Shi, J; Tian, G; Wang, X; Xu, X; Zeng, X1
Davy, A; Gautrais, J; Khuong, A; Laussu, J1
Ali-El-Dein, B; Babjuk, M; Burger, M; Chang, SS; Clayman, RH; Daneshmand, S; Efstathiou, JA; Fritsche, HM; Gakis, G; Galland, S; Hrbacek, J; Keegan, KA; Mischinger, J; Morgan, TM; Olugbade, K; Rink, M; Schubert, T; Stenzl, A; Thalmann, GN; Todenhöfer, T; Zaid, HB1
Dheen, ST; Karthikeyan, A; Ling, EA; Lu, J; Rangarajan, P1
Inagawa, H; Kohchi, C; Nisizawa, T; Saika, T; Soma, G; Uenobe, M1
Ambrosio, L; Dieleman, LA; Dunsmore, G; Elahi, S; Ghobakhloo, N; Hotte, N; Huang, V; Koleva, P; Madsen, KL; Meng, X; Nguyen, V; Sutton, R1
Caldwell, RB; Caldwell, RW; Chen, Y; Li, Z; Lian, J; Lv, H; Ni, H; Shi, G; Wu, R; Xia, Y; Xu, Y; Yao, L; Zhu, C1
Azizi, M; Bouzari, S; Fasihi-Ramandi, M; Sadeghi, Z1
Ham, DW; Kim, SG; Lee, SH; Seo, SH; Shin, EH; Shin, JH1
Chen, L; Chen, Q; Hu, J; Wu, Y; Zhu, M; Zhuang, Z1
Bao, X; Ding, H; He, JX; Miao, ZH; Song, S; Tan, J; Xiong, C; Zhang, A; Zhang, N; Zhao, J; Zhou, L1

Reviews

21 review(s) available for ifosfamide and mitomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten years.
    American journal of clinical oncology, 1992, Volume: 15, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins

1992
Nephrotoxicity from chemotherapy: prevention and management.
    Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:10

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Gallium; Humans; Ifosfamide; Kidney Diseases; Methotrexate; Mitomycin; Neoplasms; Nitrosourea Compounds; Plicamycin

1991
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Cancer, 1990, Apr-15, Volume: 65, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Remission Induction; Survival Rate; Vindesine

1990
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Cancer treatment reviews, 1983, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine

1983
Nephrological complications of cancer therapy.
    Contributions to nephrology, 1982, Volume: 33

    Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Humans; Ifosfamide; Kidney; Kidney Diseases; Methotrexate; Mitomycin; Mitomycins; Nitrosourea Compounds; Vinblastine; Vincristine

1982
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care; Survival Rate; Treatment Outcome; United Kingdom

1995
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
    Thorax, 1995, Volume: 50 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin

1995
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1996, Volume: 51, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Etoposide; Gemcitabine; Health Care Costs; Humans; Ifosfamide; Insurance, Health, Reimbursement; Italy; Lung Neoplasms; Mitomycin; Ribonucleotide Reductases; Vinblastine; Vinorelbine

1996
[The kidney in children under chemotherapy].
    Revue medicale de la Suisse romande, 1996, Volume: 116, Issue:12

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Ifosfamide; Kidney; Kidney Diseases; Kidney Function Tests; Methotrexate; Mitomycin; Semustine

1996
[Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Ifosfamide; Mitomycin; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms; Vincristine

1997
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
    Neurosurgery, 1998, Volume: 42, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine

1998
[Gynecologic cancer-evidenced based chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Evidence-Based Medicine; Female; Fluorouracil; Humans; Ifosfamide; Mitomycin; Ovarian Neoplasms; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms; Uterine Neoplasms; Vincristine

2000
Chemotherapy in metastatic non-small-cell lung cancer.
    Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:7 Suppl 5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Mitomycin; Paclitaxel; Taxoids; Tirapazamine; Triazines; Vinblastine; Vinorelbine

2000
[Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
    Revue de pneumologie clinique, 2000, Volume: 56, Issue:5

    Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Vinblastine; Vinorelbine

2000
The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Epirubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Survival Rate

2002
[ Early anti-cancer drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Vinblastine; Vindesine

2002
[The update on pancreatic cancer chemotherapy].
    Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:10

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Infusions, Intra-Arterial; Irinotecan; Male; Mitomycin; Multicenter Studies as Topic; Pancreatic Neoplasms; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Taxoids; Time Factors

2003
Compartmentalization and regulation of insulin signaling to GLUT4 by the cytoskeleton.
    Vitamins and hormones, 2009, Volume: 80

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytoskeleton; Glucose Transporter Type 4; Humans; Ifosfamide; Insulin; Mitomycin; Signal Transduction

2009
Are RAS mutations predictive markers of resistance to standard chemotherapy?
    Nature reviews. Clinical oncology, 2009, Volume: 6, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Drug Therapy; Etoposide; Genes, ras; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mutation; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome

2009
Beyond boundaries--Eph:ephrin signaling in neurogenesis.
    Cell adhesion & migration, 2014, Volume: 8, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Movement; Cisplatin; Embryonic Development; Ephrins; Female; Humans; Ifosfamide; Mitomycin; Models, Theoretical; Morphogenesis; Neurogenesis; Pregnancy; Protein Binding; Receptors, Eph Family; Signal Transduction; Stem Cells

2014

Trials

55 trial(s) available for ifosfamide and mitomycin

ArticleYear
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
    American journal of clinical oncology, 1991, Volume: 14, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Vindesine

1991
High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.
    British journal of cancer, 1991, Volume: 63, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Drug Evaluation; Humans; Ifosfamide; Lung Neoplasms; Mechlorethamine; Middle Aged; Mitomycin; Mitomycins; Survival Rate; Transplantation, Autologous

1991
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Cancer, 1990, Apr-15, Volume: 65, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Remission Induction; Survival Rate; Vindesine

1990
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
    Pneumologie (Stuttgart, Germany), 1990, Volume: 44 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Prospective Studies; Randomized Controlled Trials as Topic; Vindesine

1990
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Cancer treatment reviews, 1983, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine

1983
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
    British journal of cancer, 1995, Volume: 71, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Interferons; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins

1995
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Survival Rate; Treatment Outcome; Vindesine

1995
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; DNA Mutational Analysis; DNA, Neoplasm; Genes, ras; Genotype; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Point Mutation; Remission Induction; Survival Rate; Treatment Outcome

1995
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care; Survival Rate; Treatment Outcome; United Kingdom

1995
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
    Thorax, 1995, Volume: 50 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin

1995
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Retrospective Studies; Survival Rate; Vindesine

1995
A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1994, Volume: 6, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins

1994
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Progesterone; Prospective Studies; Remission Induction; Survival Rate; Vinblastine

1994
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Mitomycin; Mitomycins; Survival Analysis

1994
A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasm Staging; Survival Analysis

1994
MICE: a new active combination for non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:13

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Vindesine

1993
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
    Oncology, 1993, Volume: 50 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dexamethasone; Drug Administration Schedule; Furosemide; Humans; Ifosfamide; Lung Neoplasms; Mesna; Metoclopramide; Mitomycin; Mitomycins; Nausea; Neoplasm Staging; Vomiting

1993
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
    American journal of clinical oncology, 1993, Volume: 16, Issue:4

    Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Survival Analysis; Vindesine

1993
Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins; Treatment Outcome

1996
Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer.
    Seminars in oncology, 1997, Volume: 24, Issue:3 Suppl 8

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Ribonucleotide Reductases

1997
A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin

1997
A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer.
    Respirology (Carlton, Vic.), 1996, Volume: 1, Issue:1

    Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine

1996
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
    British journal of cancer, 1998, Volume: 77, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vinblastine; Vindesine

1998
Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:12

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Nausea; Quality of Life; Survival Analysis; Treatment Outcome; Vomiting

1998
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Quality of Life; Survival Analysis

1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:11

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Ifosfamide; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Sample Size; Survival Rate

1999
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.
    Lung cancer (Amsterdam, Netherlands), 1999, Volume: 26, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Evaluation Studies as Topic; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Mitomycin; Preoperative Care

1999
FILM (5-fluorouracil, ifosfamide, leucovorin and mitomycin C), an alternative chemotherapy regimen suitable for the treatment of advanced breast cancer in the 'out-patient' setting.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44 Suppl

    Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorouracil; Humans; Ifosfamide; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Outpatient Clinics, Hospital; Survival Rate; Treatment Outcome

1999
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    British journal of cancer, 2000, Volume: 83, Issue:9

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Survival Analysis; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome

2000
Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
    Nuclear medicine and biology, 2000, Volume: 27, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Membrane Permeability; Cisplatin; Doxorubicin; Etoposide; Forced Expiratory Volume; Humans; Ifosfamide; Lung; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Mitomycin; Mucociliary Clearance; Respiratory Mucosa; Technetium Tc 99m Pentetate; Vital Capacity

2000
Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2001, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome

2001
Anticipated administration of GM-CSF in the treatment of non small cell lung cancer.
    Journal of experimental & clinical cancer research : CR, 2001, Volume: 20, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Mitomycin; Recombinant Proteins; Survival Rate

2001
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-01, Volume: 20, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Preoperative Care; Proportional Hazards Models; Survival Rate

2002
The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Palliative Care; Prognosis; Quality of Life; Survival Rate; Treatment Outcome

2001
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
    Cancer, 2002, Feb-01, Volume: 94, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Injections, Subcutaneous; Leukopenia; Male; Mesna; Middle Aged; Mitomycin; Neoadjuvant Therapy; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia; Treatment Outcome; Vomiting

2002
Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 37, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Costs and Cost Analysis; Female; Home Care Services, Hospital-Based; Hospital Costs; Hospitalization; Humans; Ifosfamide; Length of Stay; Lung Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome

2002
[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Outcome

2002
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
    Cancer, 2003, Aug-01, Volume: 98, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Quality of Life; Survival Rate; Time Factors; Vinblastine

2003
Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Nov-01, Volume: 21, Issue:21

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Northern Ireland; Radiography; Survival Analysis; Treatment Outcome

2003
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Survival Rate; Thorax; Treatment Outcome

2004
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.
    Haematologica, 2004, Volume: 89, Issue:8

    Topics: Acute Disease; Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Gemtuzumab; Humans; Ifosfamide; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Mitomycin; Reproducibility of Results; Survival Analysis; Vindesine

2004
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-01, Volume: 23, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Survival Rate; Treatment Outcome

2005
Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Journal of the National Cancer Institute, 2005, Apr-06, Volume: 97, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Odds Ratio; Proportional Hazards Models; Remission Induction; Survival Analysis; Treatment Failure; Treatment Outcome; Vinblastine; Vinorelbine

2005
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2005, Volume: 49, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Radiotherapy; Time Factors; Treatment Outcome; Vindesine

2005
[Neoadjuvant chemotherapy with intra-arterial infusion in the treatment of advanced cervical cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Humans; Hysterectomy; Ifosfamide; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Vincristine

2005
Chemotherapy for metastatic NSCLC: current status and future direction.
    Nature clinical practice. Oncology, 2005, Volume: 2, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Survival Analysis; Treatment Outcome

2005
Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2005, Volume: 63, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Retrospective Studies; Treatment Outcome

2005
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Quality of Life; Survival Analysis; Taxoids; Vinblastine

2006
Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Genotype; Glutathione S-Transferase pi; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Polymorphism, Genetic; Survival Rate; Vinblastine

2006
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; DNA Repair; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Neoplasms, Squamous Cell; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Treatment Outcome

2007
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma.
    Investigational new drugs, 2008, Volume: 26, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Salvage Therapy; Survival Rate; Treatment Outcome

2008
Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial.
    Chemotherapy, 2011, Volume: 57, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Salvage Therapy

2011
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 77, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Costs and Cost Analysis; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoadjuvant Therapy; Proportional Hazards Models; Treatment Outcome; Vinblastine; Vinorelbine

2012
Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Remission Induction; Survival Rate

2012
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
    American journal of clinical oncology, 2016, Volume: 39, Issue:2

    Topics: Administration, Inhalation; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Metastasis; Postoperative Period; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Young Adult

2016

Other Studies

71 other study(ies) available for ifosfamide and mitomycin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
[Advances in the treatment of non-small cell lung cancer].
    Pathologie-biologie, 1992, Volume: 39, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Vindesine

1992
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:8 Suppl

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vinblastine

1992
Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma.
    Journal of clinical pathology, 1992, Volume: 45, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleolus; Cisplatin; Combined Modality Therapy; Cytoplasmic Granules; Esophageal Neoplasms; Female; Humans; Ifosfamide; Lysosomes; Male; Middle Aged; Mitochondria; Mitomycin; Vacuoles

1992
[Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].
    Gastroenterologie clinique et biologique, 1992, Volume: 16, Issue:3

    Topics: Animals; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Ifosfamide; Injections, Intraperitoneal; Injections, Intravenous; Male; Mitomycin; Peritoneal Neoplasms; Rats; Thiotepa

1992
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups].
    Medicina clinica, 1991, Oct-19, Volume: 97, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Iatrogenic Disease; Ifosfamide; Male; Mitomycin; Prognosis; Testicular Neoplasms; Vinblastine; Vincristine

1991
5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms; Survival Rate

1991
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins

1990
[Clinical efficacy of ifosfamide for liver metastasis of breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Ifosfamide; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Sodium; Sodium Bicarbonate

1990
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
    Pneumologie (Stuttgart, Germany), 1990, Volume: 44 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Vindesine

1990
[Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins; Peplomycin; Prostatic Neoplasms; Vincristine

1987
Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
    British journal of cancer, 1988, Volume: 58, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins

1988
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
    Onkologie, 1985, Volume: 8, Issue:4

    Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vindesine

1985
Correlation of an in vitro chemosensitivity test using [3H] incorporation with the response in case of human tumor chemotherapy.
    The Japanese journal of surgery, 1986, Volume: 16, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Carbazilquinone; Colony-Forming Units Assay; Cytarabine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Ifosfamide; Male; Mechlorethamine; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrogen Mustard Compounds; Nitrosourea Compounds; Tritium; Tumor Stem Cell Assay

1986
[A case report of an advanced ovarian cancer (stage T4) treated with a total amount of 1815 mg of CDDP].
    Gan no rinsho. Japan journal of cancer clinics, 1987, Volume: 33, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Mitomycin; Mitomycins; Ovarian Neoplasms

1987
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
    Gan no rinsho. Japan journal of cancer clinics, 1984, Volume: 30, Issue:9 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance; Fluorouracil; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Osteosarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Succinate Dehydrogenase; Vincristine

1984
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1993, Volume: 10, Issue:3-4

    Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CD57 Antigens; Cell Differentiation; Chromogranin A; Chromogranins; Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Immunologic Factors; Interferons; Karnofsky Performance Status; Life Tables; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Proteins; Neoplasm Staging; Phosphopyruvate Hydratase; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Synaptophysin; Vindesine

1993
Effects of chemotherapy on ultrastructure of oesophageal squamous cell carcinoma.
    Histopathology, 1994, Volume: 25, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Nucleus; Cisplatin; Cytoplasm; Cytoskeleton; Esophageal Neoplasms; Female; Humans; Ifosfamide; Male; Microscopy, Electron; Middle Aged; Mitomycin

1994
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Cancer research, 1994, Aug-15, Volume: 54, Issue:16

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Ifosfamide; Leukemia P388; Mammary Neoplasms, Animal; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Sarcoma, Experimental; Vinblastine

1994
Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy.
    Journal of clinical pathology, 1993, Volume: 46, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging

1993
Antitumor activity of treosulfan in human lung carcinomas.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Time Factors

1996
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
    Journal of clinical pathology, 1995, Volume: 48, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Humans; Ifosfamide; Immunoenzyme Techniques; Male; Middle Aged; Mitomycin; Neoplasm Proteins

1995
Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study.
    Lung cancer (Amsterdam, Netherlands), 1996, Volume: 15, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Vindesine

1996
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
    Journal of clinical pathology, 1997, Volume: 50, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Humans; Ifosfamide; Mitomycin

1997
Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy.
    Respiratory medicine, 1998, Volume: 92, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dermatomyositis; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care

1998
[Neoadjuvant chemotherapy for advanced cervical cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Hysterectomy; Ifosfamide; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Peplomycin; Pilot Projects; Prognosis; Uterine Cervical Neoplasms; Vinblastine; Vincristine

1999
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cohort Studies; Female; Humans; Ifosfamide; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Prognosis; Survival Analysis

1998
Characterization of a human cell clone expressing cytochrome P450 for safe use in human somatic cell therapy.
    Annals of the New York Academy of Sciences, 1999, Jun-30, Volume: 880

    Topics: Cell Division; Cell Line; Clone Cells; Cytochrome P-450 CYP2B1; Dose-Response Relationship, Drug; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Humans; Ifosfamide; Mitomycin; Safety

1999
[Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
    Archivos de bronconeumologia, 2001, Volume: 37, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinoscopy; Mediastinum; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Prognosis; Radiography; Radiotherapy, Adjuvant; Retrospective Studies; Spain; Survival Analysis; Thoracotomy; Treatment Outcome

2001
[Surgery and combined therapy for non-small cell lung cancer with invasion of the mediastinal nodes. A retrospective study].
    Archivos de bronconeumologia, 2001, Volume: 37, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Mitomycin; Neoplasm Staging; Retrospective Studies

2001
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
    Revue des maladies respiratoires, 2001, Volume: 18, Issue:4 Pt 1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Immunologic Factors; Lung Neoplasms; Mitomycin; Neoplasm Metastasis; Paclitaxel; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Vinblastine; Vinorelbine

2001
[Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer].
    Revue des maladies respiratoires, 2001, Volume: 18, Issue:4 Pt 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Follow-Up Studies; France; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multicenter Studies as Topic; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors

2001
Managing poor performance non-small-cell lung cancer patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin

2001
Neo-adjuvant chemotherapy in early stages of non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Randomized Controlled Trials as Topic

2002
A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003, Mar-15, Volume: 23, Issue:6

    Topics: Alcohol Drinking; Alcoholism; Animals; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Behavior, Animal; Choice Behavior; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Electroshock; Ethanol; Hypothermia; Ifosfamide; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitomycin; Motor Activity; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Receptors, Drug; Stress, Physiological; Substance Withdrawal Syndrome; Vindesine

2003
Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2'-deoxyuridine (RP101).
    Cancer research, 2003, Sep-15, Volume: 63, Issue:18

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cisplatin; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Fibroblasts; Ifosfamide; Methotrexate; Mice; Mitomycin; Mitoxantrone; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Sprague-Dawley; Sarcoma, Yoshida; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Vinblastine; Vinorelbine

2003
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Bioorganic & medicinal chemistry, 2004, Mar-01, Volume: 12, Issue:5

    Topics: Animals; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Cisplatin; Coumarins; DNA; Drug Resistance, Bacterial; Ifosfamide; Inhibitory Concentration 50; Macrophages; Microbial Sensitivity Tests; Mitomycin; Mycobacterium tuberculosis; Pyranocoumarins; Rifampin; RNA; Vero Cells; Virus Replication

2004
Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2004, Volume: 30, Issue:5

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Germany; Humans; Hyperthermia, Induced; Ifosfamide; Laparotomy; Liver; Middle Aged; Mitomycin; Mixed Tumor, Malignant; Mixed Tumor, Mesodermal; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Cavity; Peritoneal Neoplasms; Treatment Outcome; Women's Health

2004
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Lung cancer (Amsterdam, Netherlands), 2004, Volume: 45, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Prognosis; Survival Analysis; Survival Rate

2004
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant mixed mesodermal tumours with peritoneal dissemination.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2005, Volume: 31, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Ifosfamide; Laparotomy; Liver; Mitomycin; Mixed Tumor, Malignant; Mixed Tumor, Mesodermal; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Cavity; Peritoneal Neoplasms; Treatment Outcome; Women's Health

2005
Gene expression in primary cultured mouse hepatocytes with a cationic liposomal vector, TFL-3: comparison with rat hepatocytes.
    Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cisplatin; Gene Expression; Hepatocytes; Ifosfamide; Liposomes; Mitomycin; Rats

2005
Is the tolerance to MIP chemotherapy different between English and other European populations?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-01, Volume: 23, Issue:25

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Decision Making; Deoxycytidine; England; Europe; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Randomized Controlled Trials as Topic; Reproducibility of Results

2005
Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.
    Chest, 2005, Volume: 128, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Databases as Topic; France; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Pneumonectomy; Predictive Value of Tests; Prospective Studies; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome

2005
Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?
    Postgraduate medical journal, 2005, Volume: 81, Issue:961

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Ifosfamide; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paraneoplastic Syndromes; Radiography

2005
[Current data concerning neoadjuvant chemotherapy].
    Revue de pneumologie clinique, 2006, Volume: 62 Spec no 1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ifosfamide; Lung; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Time Factors

2006
The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.
    Journal of the American Chemical Society, 2006, Aug-02, Volume: 128, Issue:30

    Topics: Amidohydrolases; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Brain; Cannabinoid Receptor Modulators; Carbamates; Cisplatin; Endocannabinoids; Gene Deletion; Heterocyclic Compounds, 1-Ring; Hydrolases; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mitomycin; Molecular Structure; Urea

2006
[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
    Tuberkuloz ve toraks, 2006, Volume: 54, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Retrospective Studies; Survival Analysis; Treatment Outcome; Turkey

2006
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Journal of neuroimmunology, 2007, Volume: 183, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adoptive Transfer; Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Cisplatin; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glatiramer Acetate; Ifosfamide; Male; Mice; Mitomycin; Neurons; Parkinson Disease, Secondary; Peptides; Substantia Nigra; Tyrosine 3-Monooxygenase

2007
6,11-Dideoxytetrodotoxin from the puffer fish, Fugu pardalis.
    Toxicon : official journal of the International Society on Toxinology, 2007, Dec-01, Volume: 50, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Ifosfamide; Mitomycin; Molecular Structure; Ovary; Takifugu; Tetrodotoxin

2007
Combining a solution-phase derived library with in-situ cellular bioassay: prompt screening of amide-forming minilibraries using MTT assay.
    Chemical & pharmaceutical bulletin, 2009, Volume: 57, Issue:7

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Combinatorial Chemistry Techniques; Ifosfamide; Mitomycin; Models, Molecular; Molecular Structure; Small Molecule Libraries

2009
Primary squamous cell carcinoma of the breast: achieving long-term control with cisplatin-based chemotherapy.
    Clinical breast cancer, 2009, Volume: 9, Issue:3

    Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Ifosfamide; Mastectomy; Mitomycin

2009
From mouse to moose: multilocus genotyping of Giardia isolates from various animal species.
    Veterinary parasitology, 2010, Mar-25, Volume: 168, Issue:3-4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cats; Cisplatin; Cytoskeletal Proteins; Dogs; Feces; Genes, rRNA; Genotype; Giardia; Giardiasis; Host-Parasite Interactions; Ifosfamide; Mitomycin; Molecular Sequence Data; Parasitic Diseases, Animal; Phylogeny; Protozoan Proteins; Sugar Alcohol Dehydrogenases; Sweden; Triose-Phosphate Isomerase

2010
Genomic integration of adenoviral gene transfer vectors following transduction of fertilized mouse oocytes.
    Transgenic research, 2011, Volume: 20, Issue:1

    Topics: Adenoviruses, Human; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Embryo, Mammalian; Female; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; Humans; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Mitomycin; Oocytes; Recombination, Genetic; Transduction, Genetic; Transgenes; Virus Integration

2011
Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
    Arthritis and rheumatism, 2011, Volume: 63, Issue:5

    Topics: Acetylcholine; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Carbachol; Cholinergic Agonists; Cisplatin; Gastrointestinal Motility; Humans; Ifosfamide; Male; Mice; Mice, Knockout; Mitomycin; Muscle Contraction; Muscle, Smooth; Receptor, Muscarinic M3; Sjogren's Syndrome; Synaptic Transmission

2011
Inflammation: cell recruitment versus local proliferation.
    Current biology : CB, 2011, Jul-26, Volume: 21, Issue:14

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood; Cell Proliferation; Cisplatin; Filariasis; Filarioidea; Ifosfamide; Inflammation; Interleukin-4; Macrophage Activation; Macrophages; Mitomycin; Monocytes; Th2 Cells

2011
Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome.
    Nature medicine, 2013, Volume: 19, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; CCAAT-Enhancer-Binding Protein-beta; CCAAT-Enhancer-Binding Proteins; Cerebral Cortex; Cisplatin; Down Syndrome; Down-Regulation; Female; Hippocampus; Humans; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Mitomycin; Nerve Tissue Proteins; Receptors, Glutamate; Sorting Nexins; Synapses; Transcription Factors

2013
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Ifosfamide; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Taxoids

2013
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
    American journal of clinical oncology, 2016, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lower Extremity; Male; Methotrexate; Middle Aged; Mitomycin; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radiotherapy; Rare Diseases; Retroperitoneal Neoplasms; Retrospective Studies; Soft Tissue Neoplasms; Tumor Burden; Young Adult

2016
Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2015, Volume: 21, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Paclitaxel

2015
Novel influenza A(H7N2) virus in chickens, Jilin province, China, 2014.
    Emerging infectious diseases, 2014, Volume: 20, Issue:10

    Topics: Animals; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Biological Assay; Chickens; China; Cisplatin; Female; Humans; Ifosfamide; Influenza A Virus, H7N2 Subtype; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Male; Mice, Inbred BALB C; Middle Aged; Mitomycin; Orthomyxoviridae Infections; Virus Replication

2014
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Paclitaxel; Perioperative Care; Retrospective Studies; Urethra; Urethral Neoplasms; Urinary Diversion

2015
Sirtuin 3 regulates Foxo3a-mediated antioxidant pathway in microglia.
    Neuroscience, 2015, Dec-17, Volume: 311

    Topics: Active Transport, Cell Nucleus; Animals; Animals, Newborn; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Brain Injuries; Catalase; Cell Line; Cisplatin; Corpus Callosum; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Knockdown Techniques; Ifosfamide; Lipopolysaccharides; Mice, Knockout; Microglia; Mitomycin; Rats, Wistar; Reactive Oxygen Species; Sirtuin 3; Sirtuins; Superoxide Dismutase

2015
Dewaxed Brown Rice Contains a Significant Amount of Lipopolysaccharide Pointing to Macrophage Activation via TLRs.
    Anticancer research, 2016, Volume: 36, Issue:7

    Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Ifosfamide; Immunity, Innate; Lipopolysaccharides; Macrophage Activation; Mice; Mitomycin; Nitric Oxide; Oryza; RAW 264.7 Cells; Toll-Like Receptor 4; Waxes

2016
Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy.
    Journal of Crohn's & colitis, 2019, Feb-01, Volume: 13, Issue:2

    Topics: Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Models, Animal; Erythroid Cells; Female; Humans; Ifosfamide; Inflammatory Bowel Diseases; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitomycin; Pregnancy; Pregnancy Complications; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Transferrin; Transcriptome

2019
Chronic mild stress induced anxiety-like behaviors can Be attenuated by inhibition of NOX2-derived oxidative stress.
    Journal of psychiatric research, 2019, Volume: 114

    Topics: Acetophenones; Animals; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cisplatin; Hippocampus; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mitomycin; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Stress, Psychological

2019
Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Journal of biotechnology, 2020, Feb-20, Volume: 310

    Topics: Animals; Antigens, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Brucella abortus; Brucella melitensis; Brucella Vaccine; Brucellosis; Chitosan; Cisplatin; Female; Ifosfamide; Mannose; Mice, Inbred BALB C; Mitomycin; Nanoparticles

2020
Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Brain; Cisplatin; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Fluorescent Antibody Technique; Ifosfamide; Interleukin-17; Mice, Inbred C57BL; Mitomycin; Suppressor of Cytokine Signaling 3 Protein; Th17 Cells; Toxoplasmosis

2021
MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis.
    International journal of molecular medicine, 2021, Volume: 47, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemokine CXCL12; Cisplatin; Colorectal Neoplasms; HT29 Cells; Humans; Ifosfamide; Male; Mice, Inbred BALB C; Mice, Nude; Microfilament Proteins; Mitomycin; Neoplasm Metastasis; Neoplasm Proteins; Receptors, CXCR4; Signal Transduction

2021
Development of Potent NEDD8-Activating Enzyme Inhibitors Bearing a Pyrimidotriazole Scaffold.
    Journal of medicinal chemistry, 2021, 05-13, Volume: 64, Issue:9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Drug Design; Enzyme Inhibitors; Humans; Ifosfamide; Mitomycin; Tirapazamine; Tissue Distribution; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays

2021